California Public Employees Retirement System’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-19,490
Closed -$721K 1782
2021
Q1
$721K Sell
19,490
-1,839
-9% -$73.2K ﹤0.01% 2727
2020
Q4
$707K Buy
+21,329
New +$619K ﹤0.01% 2706

Other funds holding CCCC

California Public Employees Retirement System's CCCC Position: Q2 2021 in Review

California Public Employees Retirement System sold out of C4 Therapeutics (CCCC) in Q2 2021, closing a stake of 19,490 shares — an estimated $721K sold.

California Public Employees Retirement System first reported a position in CCCC in Q4 2020 and held it in 2 quarters. The position peaked at $721K in Q1 2021. 107 funds tracked by Wall St. Rank hold CCCC as of Q2 2021.

  • California Public Employees Retirement System reported no remaining C4 Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 19,490 C4 Therapeutics shares in Q2 2021, an estimated $721K.
  • California Public Employees Retirement System first reported a position in C4 Therapeutics in Q4 2020 and held it in 2 quarters.
  • California Public Employees Retirement System's C4 Therapeutics position peaked at $721K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.